 |
PDBsum entry 2esp
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Ligase
|
 |
|
Title:
|
 |
Human ubiquitin-conjugating enzyme (e2) ubch5b mutant ile88ala
|
|
Structure:
|
 |
Ubiquitin-conjugating enzyme e2 d2. Chain: a. Synonym: ubiquitin-protein ligase d2, ubiquitin carrier protein d2, ubiquitin-conjugating enzyme e2-17 kda 2, e217, kb 2. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ube2d2, ubc4, ubch5b. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
1.52Å
|
R-factor:
|
0.187
|
R-free:
|
0.233
|
|
|
Authors:
|
 |
E.Ozkan,H.Yu,J.Deisenhofer
|
Key ref:
|
 |
E.Ozkan
et al.
(2005).
Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.
Proc Natl Acad Sci U S A,
102,
18890-18895.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
26-Oct-05
|
Release date:
|
06-Dec-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P62837
(UB2D2_HUMAN) -
Ubiquitin-conjugating enzyme E2 D2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
147 a.a.
149 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.3.2.23
- E2 ubiquitin-conjugating enzyme.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L- cysteine
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.2.3.2.24
- (E3-independent) E2 ubiquitin-conjugating enzyme.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N6- monoubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
102:18890-18895
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.
|
|
E.Ozkan,
H.Yu,
J.Deisenhofer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Ubiquitin-conjugating enzymes (E2s) collaborate with the ubiquitin-activating
enzyme (E1) and ubiquitin ligases (E3s) to attach ubiquitin to target proteins.
RING-containing E3s simultaneously bind to E2s and substrates, bringing them
into close proximity and thus facilitating ubiquitination. We show herein that,
although the E3-binding site on the human E2 UbcH5b is distant from its active
site, two RING-type minimal E3 modules lacking substrate-binding functions
greatly stimulate the rate of ubiquitin release from the UbcH5b-ubiquitin
thioester. Using statistical coupling analysis and mutagenesis, we identify and
characterize clusters of coevolving and functionally linked residues within
UbcH5b that span its E3-binding and active sites. Several UbcH5b mutants are
defective in their stimulation by E3s despite their abilities to bind to these
E3s, to form ubiquitin thioesters, and to release ubiquitin at a basal rate. One
such mutation, I37A, is distant from both the active site and the E3-binding
site of UbcH5b. Our studies reveal structural determinants for communication
between distal functional sites of E2s and suggest that RING-type E3s activate
E2s allosterically.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. SCA of E2s. (A) Hierarchical clustering of a
submatrix of pairwise statistical coupling energies of E2
residues, which are plotted as a color gradient, with blue and
red representing the lowest (0 kT*, with kT* being an arbitrary
energy-like unit) and highest (2 kT*) energies, respectively.
Both columns and rows of the matrix represent residue positions
in UbcH7 and UbcH5b (in parentheses). The two clusters of
residues that exhibit similar coupling patterns are boxed with
dashed lines. (B) The two clusters of residues in A are shown as
space-filling models and mapped onto the structure of UbcH5b.
Cluster I and II residues are colored green and cyan,
respectively. E3-binding residues are shown in red. The
active-site cysteine and asparagine are labeled.
|
 |
Figure 2.
Fig. 2. E3-stimulated release of ubiquitin from the
UbcH5b-ubiquitin thioester. (A) WT and 31 mutants of UbcH5b were
tested for their ability to release ubiquitin from their
thioesters in the presence of buffer (-) or Apc2/11 (+) with
continuous E1-catalyzed ubiquitin charging. The bands
corresponding to free UbcH5b, UbcH5b-ubiquitin thioester, and
monoubiquitinated UbcH5b (with isopeptide-linked ubiquitin) are
indicated. (B) Same as in A except that CNOT4N was used as the
E3. (C) UbcH5b I88A was defective in supporting
APC/C^Cdh1-mediated ubiquitination of cyclin B1. Xenopus egg
APC/C was incubated with buffer or Cdh1 and assayed for its
ability to ubiquitinate an N-terminal fragment (residues 1-102)
of human cyclin B1 in the presence of the varying concentrations
of WT or mutant UbcH5b. Cyclin B-ubiquitin conjugates are
indicated.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Dou,
L.Buetow,
G.J.Sibbet,
K.Cameron,
and
D.T.Huang
(2012).
BIRC7-E2 ubiquitin conjugate structure reveals the mechanism of ubiquitin transfer by a RING dimer.
|
| |
Nat Struct Mol Biol,
19,
876-883.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.M.Wenzel,
A.Lissounov,
P.S.Brzovic,
and
R.E.Klevit
(2011).
UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids.
|
| |
Nature,
474,
105-108.
|
 |
|
|
|
|
 |
Y.Zhang,
X.Zhou,
L.Zhao,
C.Li,
H.Zhu,
L.Xu,
L.Shan,
X.Liao,
Z.Guo,
and
P.Huang
(2011).
UBE2W interacts with FANCL and regulates the monoubiquitination of fanconi anemia protein FANCD2.
|
| |
Mol Cells,
31,
113-122.
|
 |
|
|
|
|
 |
A.G.Eldridge,
and
T.O'Brien
(2010).
Therapeutic strategies within the ubiquitin proteasome system.
|
| |
Cell Death Differ,
17,
4.
|
 |
|
|
|
|
 |
A.Pastore
(2010).
Further insights into the ubiquitin pathway: understanding the scarlet letter code.
|
| |
Structure,
18,
891-892.
|
 |
|
|
|
|
 |
C.W.Liew,
H.Sun,
T.Hunter,
and
C.L.Day
(2010).
RING domain dimerization is essential for RNF4 function.
|
| |
Biochem J,
431,
23-29.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.C.Scott,
J.K.Monda,
C.R.Grace,
D.M.Duda,
R.W.Kriwacki,
T.Kurz,
and
B.A.Schulman
(2010).
A dual E3 mechanism for Rub1 ligation to Cdc53.
|
| |
Mol Cell,
39,
784-796.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.C.Rodrigo-Brenni,
S.A.Foster,
and
D.O.Morgan
(2010).
Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin.
|
| |
Mol Cell,
39,
548-559.
|
 |
|
|
|
|
 |
M.Krzeminski,
K.Loth,
R.Boelens,
and
A.M.Bonvin
(2010).
SAMPLEX: automatic mapping of perturbed and unperturbed regions of proteins and complexes.
|
| |
BMC Bioinformatics,
11,
51.
|
 |
|
|
|
|
 |
P.D.Mace,
S.Shirley,
and
C.L.Day
(2010).
Assembling the building blocks: structure and function of inhibitor of apoptosis proteins.
|
| |
Cell Death Differ,
17,
46-53.
|
 |
|
|
|
|
 |
Q.Cheng,
and
J.Chen
(2010).
Mechanism of p53 stabilization by ATM after DNA damage.
|
| |
Cell Cycle,
9,
472-478.
|
 |
|
|
|
|
 |
Q.S.Du,
C.H.Wang,
S.M.Liao,
and
R.B.Huang
(2010).
Correlation analysis for protein evolutionary family based on amino acid position mutations and application in PDZ domain.
|
| |
PLoS One,
5,
e13207.
|
 |
|
|
|
|
 |
R.C.Benirschke,
J.R.Thompson,
Y.Nominé,
E.Wasielewski,
N.Juranić,
S.Macura,
S.Hatakeyama,
K.I.Nakayama,
M.V.Botuyan,
and
G.Mer
(2010).
Molecular basis for the association of human E4B U box ubiquitin ligase with E2-conjugating enzymes UbcH5c and Ubc4.
|
| |
Structure,
18,
955-965.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Wu,
J.P.Acevedo,
and
M.T.Reetz
(2010).
Induced allostery in the directed evolution of an enantioselective Baeyer-Villiger monooxygenase.
|
| |
Proc Natl Acad Sci U S A,
107,
2775-2780.
|
 |
|
|
|
|
 |
W.Tang,
J.Q.Wu,
C.Chen,
C.S.Yang,
J.Y.Guo,
C.D.Freel,
and
S.Kornbluth
(2010).
Emi2-mediated inhibition of E2-substrate ubiquitin transfer by the anaphase-promoting complex/cyclosome through a D-box-independent mechanism.
|
| |
Mol Biol Cell,
21,
2589-2597.
|
 |
|
|
|
|
 |
C.J.Tsai,
A.Del Sol,
and
R.Nussinov
(2009).
Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms.
|
| |
Mol Biosyst,
5,
207-216.
|
 |
|
|
|
|
 |
C.M.Carlile,
C.M.Pickart,
M.J.Matunis,
and
R.E.Cohen
(2009).
Synthesis of free and proliferating cell nuclear antigen-bound polyubiquitin chains by the RING E3 ubiquitin ligase Rad5.
|
| |
J Biol Chem,
284,
29326-29334.
|
 |
|
|
|
|
 |
C.Michelle,
P.Vourc'h,
L.Mignon,
and
C.R.Andres
(2009).
What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor?
|
| |
J Mol Evol,
68,
616-628.
|
 |
|
|
|
|
 |
G.Markson,
C.Kiel,
R.Hyde,
S.Brown,
P.Charalabous,
A.Bremm,
J.Semple,
J.Woodsmith,
S.Duley,
K.Salehi-Ashtiani,
M.Vidal,
D.Komander,
L.Serrano,
P.Lehner,
and
C.M.Sanderson
(2009).
Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network.
|
| |
Genome Res,
19,
1905-1911.
|
 |
|
|
|
|
 |
H.B.Kamadurai,
J.Souphron,
D.C.Scott,
D.M.Duda,
D.J.Miller,
D.Stringer,
R.C.Piper,
and
B.A.Schulman
(2009).
Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex.
|
| |
Mol Cell,
36,
1095-1102.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Liu,
and
R.Nussinov
(2009).
The mechanism of ubiquitination in the cullin-RING E3 ligase machinery: conformational control of substrate orientation.
|
| |
PLoS Comput Biol,
5,
e1000527.
|
 |
|
|
|
|
 |
J.Wang,
and
B.A.Schulman
(2009).
(G2)BRinging an E2 to E3.
|
| |
Structure,
17,
916-917.
|
 |
|
|
|
|
 |
M.E.Matyskiela,
M.C.Rodrigo-Brenni,
and
D.O.Morgan
(2009).
Mechanisms of ubiquitin transfer by the anaphase-promoting complex.
|
| |
J Biol,
8,
92.
|
 |
|
|
|
|
 |
R.Das,
J.Mariano,
Y.C.Tsai,
R.C.Kalathur,
Z.Kostova,
J.Li,
S.G.Tarasov,
R.L.McFeeters,
A.S.Altieri,
X.Ji,
R.A.Byrd,
and
A.M.Weissman
(2009).
Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78.
|
| |
Mol Cell,
34,
674-685.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.J.Deshaies,
and
C.A.Joazeiro
(2009).
RING domain E3 ubiquitin ligases.
|
| |
Annu Rev Biochem,
78,
399-434.
|
 |
|
|
|
|
 |
S.B.Qian,
L.Waldron,
N.Choudhary,
R.E.Klevit,
W.J.Chazin,
and
C.Patterson
(2009).
Engineering a ubiquitin ligase reveals conformational flexibility required for ubiquitin transfer.
|
| |
J Biol Chem,
284,
26797-26802.
|
 |
|
|
|
|
 |
S.J.van Wijk,
S.J.de Vries,
P.Kemmeren,
A.Huang,
R.Boelens,
A.M.Bonvin,
and
H.T.Timmers
(2009).
A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system.
|
| |
Mol Syst Biol,
5,
295.
|
 |
|
|
|
|
 |
W.Li,
D.Tu,
L.Li,
T.Wollert,
R.Ghirlando,
A.T.Brunger,
and
Y.Ye
(2009).
Mechanistic insights into active site-associated polyubiquitination by the ubiquitin-conjugating enzyme Ube2g2.
|
| |
Proc Natl Acad Sci U S A,
106,
3722-3727.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Ye,
and
M.Rape
(2009).
Building ubiquitin chains: E2 enzymes at work.
|
| |
Nat Rev Mol Cell Biol,
10,
755-764.
|
 |
|
|
|
|
 |
A.Saha,
and
R.J.Deshaies
(2008).
Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation.
|
| |
Mol Cell,
32,
21-31.
|
 |
|
|
|
|
 |
K.Linke,
P.D.Mace,
C.A.Smith,
D.L.Vaux,
J.Silke,
and
C.L.Day
(2008).
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
|
| |
Cell Death Differ,
15,
841-848.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.K.Summers,
B.Pan,
K.Mukhyala,
and
P.K.Jackson
(2008).
The unique N terminus of the UbcH10 E2 enzyme controls the threshold for APC activation and enhances checkpoint regulation of the APC.
|
| |
Mol Cell,
31,
544-556.
|
 |
|
|
|
|
 |
R.Perez-Jimenez,
A.P.Wiita,
D.Rodriguez-Larrea,
P.Kosuri,
J.A.Gavira,
J.M.Sanchez-Ruiz,
and
J.M.Fernandez
(2008).
Force-clamp spectroscopy detects residue co-evolution in enzyme catalysis.
|
| |
J Biol Chem,
283,
27121-27129.
|
 |
|
|
|
|
 |
B.T.Dye,
and
B.A.Schulman
(2007).
Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins.
|
| |
Annu Rev Biophys Biomol Struct,
36,
131-150.
|
 |
|
|
|
|
 |
M.C.Rodrigo-Brenni,
and
D.O.Morgan
(2007).
Sequential E2s drive polyubiquitin chain assembly on APC targets.
|
| |
Cell,
130,
127-139.
|
 |
|
|
|
|
 |
O.Kerscher,
R.Felberbaum,
and
M.Hochstrasser
(2006).
Modification of proteins by ubiquitin and ubiquitin-like proteins.
|
| |
Annu Rev Cell Dev Biol,
22,
159-180.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |